Characterize the T-cell repertoire with NGS ease

Enable Your Next Breakthrough

Accurate characterization of T-cell repertoires is key to understanding the adaptive immune response in cancer. This information has many applications, including: studying minimal residual disease in cancer, vaccine development for infectious disease and characterizing auto-immunity.

QIAGEN has recently launched the QIAseq Immune Repertoire RNA Library Kit which measures the complexity of the T-cell repertoire in a single panel, contained in a single tube. This greatly reduces the time to prepare a sample for sequencing, as well as sequencing costs. This library kit also comes with an integrated data analysis suite that goes beyond the variant calling file to include a clonotype report, CDR3 length plots, the ability to compare samples, and more.

Visit us at booth #5113 to learn more about the new QIAseq T Cell Repertoire Kit and upcoming products including the QIAseq Tumor Mutation Burden-MSI kits!


QIAseq T-Cell Repertoire Kits and QIAseq Tumor Mutation Burden MSI Kits are intended for molecular biology applications. These products are not intended for the diagnosis, prevention, or treatment of a disease.

Visit us at the 2018 ASCO Annual Meeting, Booth #5113

Social Sharing